Effect of cardiac resynchronization therapy in patients with new york heart association functional class IV heart failure

American Journal of Cardiology

Volumn 106, Issue 8, 2010, Pages 1146-1151

  Van Bommel, Rutger J ^a   Van Rijnsoever, Eva ^a   Borleffs, C Jan Willem ^a   Delgado, Victoria ^a   Marsan, Nina Ajmone ^a   Bertini, Matteo ^a   Schalij, Martin J ^a   Bax, Jeroen J ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; DETERIORATION; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HOSPITALIZATION; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; CARDIOVERSION; CLASSIFICATION; COMPARATIVE STUDY; ECHOGRAPHY; HEART CONTRACTION; HEART LEFT VENTRICLE FUNCTION; HEART VENTRICLE; HEART VOLUME; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; PROGNOSIS; QUALITY OF LIFE; QUESTIONNAIRE; SEVERITY OF ILLNESS INDEX; TIME;

AGED; CARDIAC VOLUME; DEFIBRILLATORS, IMPLANTABLE; ECHOCARDIOGRAPHY; ELECTRIC COUNTERSHOCK; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HEART VENTRICLES; HUMANS; MALE; MYOCARDIAL CONTRACTION; PROGNOSIS; QUALITY OF LIFE; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; TIME FACTORS; VENTRICULAR FUNCTION, LEFT;

EID: 77957804599     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2010.06.025     Document Type: Article

References (21)

1. V.L. Roger, S.A. Weston, M.M. Redfield, J.P. Hellermann-Homan, J. Killian, B.P. Yawn, and S.J. Jacobsen Trends in heart failure incidence and survival in a community-based population JAMA 292 2004 344 350
2. S.A. Strickberger, J. Conti, E.G. Daoud, E. Havranek, M.R. Mehra, I.L. Pina, and J. Young Patient selection for cardiac resynchronization therapy: from the Council on Clinical Cardiology Subcommittee on Electrocardiography and Arrhythmias and the Quality of Care and Outcomes Research Interdisciplinary Working Group, in collaboration with the Heart Rhythm Society Circulation 111 2005 2146 2150
3. W.T. Abraham, W.G. Fisher, A.L. Smith, D.B. DeLurgio, A.R. Leon, E. Loh, D.Z. Kocovic, M. Packer, A.L. Clavell, D.L. Hayes, M. Ellestad, R.J. Trupp, J. Underwood, F. Pickering, C. Truex, P. McAtee, and J. Messenger Cardiac resynchronization in chronic heart failure N Engl J Med 346 2002 1845 1853
4. J.G. Cleland, J.C. Daubert, E. Erdmann, N. Freemantle, D. Gras, L. Kappenberger, and L. Tavazzi The effect of cardiac resynchronization on morbidity and mortality in heart failure N Engl J Med 352 2005 1539 1549 (Pubitemid 40517094)
5. M.H. Lehmann, and K.D. Aaronson CRT-D therapy in heart failure: how much do NYHA class IV patients benefit? J Cardiovasc Electrophysiol 17 2006 491 494
6. T.S. Rector, S.H. Kubo, and J.N. Cohn Validity of the Minnesota Living with Heart Failure questionnaire as a measure of therapeutic response to enalapril or placebo Am J Cardiol 71 1993 1106 1107
7. G.H. Guyatt, M.J. Sullivan, P.J. Thompson, E.L. Fallen, S.O. Pugsley, D.W. Taylor, and L.B. Berman The 6-minute walk: a new measure of exercise capacity in patients with chronic heart failure CMAJ 132 1985 919 923
8. N.B. Schiller, P.M. Shah, M. Crawford, A. DeMaria, R. Devereux, H. Feigenbaum, H. Gutgesell, N. Reichek, D. Sahn, and I. Schnittger Recommendations for quantitation of the left ventricle by two-dimensional echocardiography American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms J Am Soc Echocardiogr 2 1989 358 367
9. R.O. Bonow, B.A. Carabello, K. Chatterjee, A.C. de Leon Jr, D.P. Faxon, M.D. Freed, W.H. Gaasch, B.W. Lytle, R.A. Nishimura, P.T. O'Gara, R.A. O'Rourke, C.M. Otto, P.M. Shah, and J.S. Shanewise 2008 Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 guidelines for the management of patients with valvular heart disease) Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons J Am Coll Cardiol 52 suppl 2008 e1 e142
10. M. Packer Proposal for a new clinical end point to evaluate the efficacy of drugs and devices in the treatment of chronic heart failure J Card Fail 7 2001 176 182
11. D. Gras, C. Leclercq, A.S. Tang, C. Bucknall, H.O. Luttikhuis, and A. Kirstein-Pedersen Cardiac resynchronization therapy in advanced heart failure the multicenter InSync clinical study Eur J Heart Fail 4 2002 311 320
12. M.R. Bristow, L.A. Saxon, J. Boehmer, S. Krueger, D.A. Kass, T. De Marco, P. Carson, L. DiCarlo, D. DeMets, B.G. White, D.W. DeVries, and A.M. Feldman Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure N Engl J Med 350 2004 2140 2150
13. M.G. St John Sutton, T. Plappert, W.T. Abraham, A.L. Smith, D.B. DeLurgio, A.R. Leon, E. Loh, D.Z. Kocovic, W.G. Fisher, M. Ellestad, J. Messenger, K. Kruger, K.E. Hilpisch, and M.R. Hill Effect of cardiac resynchronization therapy on left ventricular size and function in chronic heart failure Circulation 107 2003 1985 1990
14. M.S. Sutton, and M.G. Keane Reverse remodelling in heart failure with cardiac resynchronisation therapy Heart 93 2007 167 171
15. J.L. Anderson, H. Krause-Steinrauf, S. Goldman, B.S. Clemson, M.J. Domanski, W.D. Hager, D.R. Murray, D.L. Mann, B.M. Massie, D.M. McNamara, R. Oren, and W.J. Rogers Failure of benefit and early hazard of bucindolol for Class IV heart failure J Card Fail 9 2003 266 277
16. L.W. Stevenson, L.W. Miller, P. Desvigne-Nickens, D.D. Ascheim, M.K. Parides, D.G. Renlund, R.M. Oren, S.K. Krueger, M.R. Costanzo, L.S. Wann, R.G. Levitan, and D. Mancini Left ventricular assist device as destination for patients undergoing intravenous inotropic therapy: a subset analysis from REMATCH (Randomized Evaluation of Mechanical Assistance in Treatment of Chronic Heart Failure) Circulation 110 2004 975 981
17. J. Lindenfeld, A.M. Feldman, L. Saxon, J. Boehmer, P. Carson, J.K. Ghali, I. Anand, S. Singh, J.S. Steinberg, B. Jaski, T. DeMarco, D. Mann, P. Yong, E. Galle, F. Ecklund, and M. Bristow Effects of cardiac resynchronization therapy with or without a defibrillator on survival and hospitalizations in patients with New York Heart Association class IV heart failure Circulation 115 2007 204 212
18. B. Herweg, A. Ilercil, R. Cutro, R. Dewhurst, S. Krishnan, M. Weston, and S.S. Barold Cardiac resynchronization therapy in patients with end-stage inotrope-dependent class IV heart failure Am J Cardiol 100 2007 90 93
19. P.J. Cowburn, H. Patel, R.E. Jolliffe, R.W. Wald, and J.D. Parker Cardiac resynchronization therapy: an option for inotrope-supported patients with end-stage heart failure? Eur J Heart Fail 7 2005 215 217
20. A. Al-Ahmad, W.M. Rand, G. Manjunath, M.A. Konstam, D.N. Salem, A.S. Levey, and M.J. Sarnak Reduced kidney function and anemia as risk factors for mortality in patients with left ventricular dysfunction J Am Coll Cardiol 38 2001 955 962
21. F.A. McAlister, J. Ezekowitz, M. Tonelli, and P.W. Armstrong Renal insufficiency and heart failure: prognostic and therapeutic implications from a prospective cohort study Circulation 109 2004 1004 1009